Article Details

Immune-Onc Therapeutics Doses First Patient in Phase 1 Clinical Trial of IO-202, a First ... - WVNews

Retrieved on: 2022-04-12 20:43:17

Tags for this article:

Click the tags to see associated articles and topics

Immune-Onc Therapeutics Doses First Patient in Phase 1 Clinical Trial of IO-202, a First ... - WVNews. View article details on hiswai:

Excerpt

... unleashing the antitumor activities of the immune system and increasing the therapeutic benefit of T cell checkpoint inhibitors.

Article found on: www.wvnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up